Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

Hangzhou Endonom Medtech Co., Ltd.

Clinical trials sponsored by Hangzhou Endonom Medtech Co., Ltd., explained in plain language.

Trials to join now! 2 Not yet recruiting 1 Completed 1
Sort by
  • New plug could boost aortic repair success

    Disease control Recruiting now

    This study tests whether adding a special plug (WeFlow-EndoSeal™) to standard stent-graft repair improves outcomes for people with a tear in the aorta's inner layer (type B aortic dissection). About 256 adults with subacute or chronic dissection will be randomly assigned to get t…

    Phase: NA • Sponsor: Hangzhou Endonom Medtech Co., Ltd. • Aim: Disease control

    Last updated Jun 27, 2026 14:01 UTC

  • New stent aims to fix deadly aortic aneurysms without open surgery

    Disease control Recruiting now

    This study tests a new device called the WeFlow-Tribranch stent graft system to repair aneurysms or ulcers in the aortic arch. About 90 people aged 18 to 80 with these conditions will receive the stent through a minimally invasive procedure. The main goal is to see if the device …

    Phase: NA • Sponsor: Hangzhou Endonom Medtech Co., Ltd. • Aim: Disease control

    Last updated Jun 27, 2026 12:28 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space